These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 775144)

  • 21. [The single daily dose of gentamicin in the treatment of urinary tract infections (author's transl)].
    Angelov A; Barrientos G; Gutensohn G; Lenzner A
    MMW Munch Med Wochenschr; 1980 Feb; 122(6):212-4. PubMed ID: 6767959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The therapy of bacterial urinary tract infections with gentamicin administered in a single daily dose (author's transl)].
    Prát V; Bohuslav V; Hatala M; Morávek J
    Cas Lek Cesk; 1977 Nov; 116(46):1434-7. PubMed ID: 597827
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of urinary tract infections with amikacin (BB-K8) (author's transl)].
    Hirokawa I; Nakano I; Okada K; Higaki M; Akima S
    Jpn J Antibiot; 1974 Apr; 27(2):193-201. PubMed ID: 4603934
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].
    Konya H; Kuroda J; Iwao N; Morita M
    Jpn J Antibiot; 1978 Jul; 31(7):341-5. PubMed ID: 691255
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative non-blind trial of ceftriaxone and gentamicin in the treatment of complicated urinary tract infections.
    Lentini M; Castiello G; Scorza C; Calvosa F
    J Int Med Res; 1982; 10(3):166-78. PubMed ID: 6284564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical experience with amikacin (BB-K8) (author's transl)].
    Nakagawa K; Watanabe K; Kabe J; Suzuki T; Koyama S
    Jpn J Antibiot; 1974 Jun; 27(3):337-42. PubMed ID: 4215897
    [No Abstract]   [Full Text] [Related]  

  • 27. Gentamicin for urinary-tract infections in infants.
    Howard JE; Donoso E; Mimica I; Zilleruelo G
    J Infect Dis; 1971 Dec; 124 Suppl():S234-5. PubMed ID: 5001623
    [No Abstract]   [Full Text] [Related]  

  • 28. [Laboratory and clinical investigation of amikacin (BB-K8) (author's transl)].
    Kato Y; Saito A; Ishikawa K; Nakayama I; Tomizawa M
    Jpn J Antibiot; 1974 Jun; 27(3):343-7. PubMed ID: 4215898
    [No Abstract]   [Full Text] [Related]  

  • 29. [Laboratory and clinical experiments of gentamicin with special reference to in vitro antibacterial activity, disc-sensitivity test and body fluid concentration assay methods].
    Kanazawa Y; Kuramata T
    Jpn J Antibiot; 1968 Dec; 21(6):342-9. PubMed ID: 4887885
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].
    Nishiura T; Kawada Y; Ichikawa T; Nakano I; Tsuji I; Kumamoto Y; Shishido S
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar; 69(3):381-98. PubMed ID: 351248
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy, tolerance, and pharmacokinetics of sisomicin in urinary tract infections (author's transl)].
    Dobbelstein H; Isbary E; Lang W
    Infection; 1978; 6(6):271-6. PubMed ID: 103844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gentamicin therapy of infectious diseases by pathogens (author's transl)].
    Okamoto Y; Okubo H; Uba F; Ueda Y
    Jpn J Antibiot; 1976 Mar; 29(3):247-55. PubMed ID: 1271580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluations of netilmicin in urinary tract infections].
    Saito I
    Jpn J Antibiot; 1982 Aug; 35(8):1925-33. PubMed ID: 7154243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activity of gentamicin on some bacterial species responsible for urinary tract infections. Clinical and bacteriological results].
    Di Grazia G; Pisano A
    G Ital Chemioter; 1969; 16(1):105-9. PubMed ID: 5404082
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study on netilmicin in the treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa].
    Murahashi I; Honda M; Maeda S; Takasaki E
    Jpn J Antibiot; 1982 Aug; 35(8):1919-24. PubMed ID: 6818388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical trial of HAPA-B in complicated urinary tract infections].
    Kamiryo Y; Kato M; Sanefuji T; Hirao H
    Hinyokika Kiyo; 1986 Sep; 32(9):1379-85. PubMed ID: 3101447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacterial flora and current problems of resistence in urinary tract infections (author's transl)].
    Peters HJ; Ludwig G; Ueberle W
    Med Klin; 1973 Sep; 68(39):1265-71. PubMed ID: 4201041
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin.
    Madsen PO; Kjaer TB; Mosegaard A
    Urology; 1977 Jun; 9(6):635-8. PubMed ID: 329522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses.
    Orsini JA; Benson CE; Spencer PA; Van Miller E
    Am J Vet Res; 1989 Jun; 50(6):923-5. PubMed ID: 2669575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and fundamental studies on intravenous drip infusion of gentamicin in the pediatric field. Pediatric study group of gentamicin].
    Ichihashi Y; Hori M; Tatsuzawa O; Okabe N; Wakasugi H; Yoshioka H; Fujita K; Sakata H; Ishida C; Kakehashi H
    Jpn J Antibiot; 1988 May; 41(5):538-48. PubMed ID: 3216476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.